You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Mexico approves AstraZeneca's coronavirus vaccine for emergency use

Mexico approved the Oxford-AstraZeneca coronavirus vaccine for emergency use Monday, hoping to spur a halting vaccination effort that has only given about 44,000 shots since the third week of December

Topics
AstraZeneca | Mexico | Coronavirus Vaccine

AP  |  Mexico City 

Photo: Reuters
AstraZeneca vaccine

approved the Oxford-for emergency use Monday, hoping to spur a halting vaccination effort that has only given about 44,000 shots since the third week of December, about 82 per cent of the doses the country has received.

Prior to this, the Pfizer vaccine was the only one approved for use in Mexican regulators approved the shot. Assistant Health Secretariat Hugo Lpez-Gatell said he erroneously reported approval for Chinese vaccine maker CanSino, noting it had not yet submitted full study results for safety and efficacy.

has pinned much of its hopes on the inexpensive, one-shot CanSino vaccine. It will makes things a lot easier for us, Lpez-Gatell said.

Lpez-Gatell, who heads up efforts to deal with the pandemic, had to explain why he was spotted at a Pacific coast beach, apparently sitting at sea-side restaurant without a face mask on.

Lpez-Gatell has repeatedly counselled Mexicans to stay at home. He has also cast doubt on how whether face masks protect people from catching coronavirus.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, January 05 2021. 08:50 IST
RECOMMENDED FOR YOU